Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Costa-Scharplatz
Dose Increase Beyond Labelled Dose of Biologic Treatments in Psoriasis Patients: A Real-World Study in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in the Real World: Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy
PLoS ONE
Multidisciplinary
Drug Survival of Secukinumab in Real-World Plaque Psoriasis Patients: A 52-Week, Multicenter, Retrospective Study
Journal of the American Academy of Dermatology
Dermatology
Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy103 - Modelling Average Cost and Cost-Per-Responder for Biological Treatments for Moderate-To-Severe Plaque Psoriasis With Dose Escalation and Real-World Drug Survival
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
‘Real-World’ Effectiveness of Smoking Cessation Treatments: A Population Study
Addiction
Medicine
Psychiatry
Mental Health
Dose-Creep of Infliximab During Psoriasis Treatment: An Observational Study
Acta Dermato-Venereologica
Dermatology
Medicine
Experience of Using a Fixed-Dose Combination of Perindopril and Amlodipine in the Clinical Practice Settings: A Real-World Opportunity to Increase Antihypertensive Therapy Effectiveness
Russian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Persistence and Failure Rates of Adalimumab Monotherapy in Biologic-Naïve Patients With Psoriasis: A Retrospective Study
Journal of the American Academy of Dermatology
Dermatology
